DHR vs SBUX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Starbucks Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Starbucks Corporation · Consumer Cyclical
$96.67
+12.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
SBUX |
| Current Price |
$221.12 |
$96.67 |
| Fair Value Estimate |
$286.52 |
$108.52 |
| Upside to Fair Value |
+29.6%
|
+12.3%
|
| Market Cap |
$155.4B |
$110.2B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
22.0x
|
| Price / Sales |
6.2x
|
2.9x
|
| Price / FCF |
28.5x
|
30.4x
|
| Revenue Growth YoY |
+5.5%
|
-1.4%
|
| Gross Margin |
58.5%
|
31.7%
|
| Operating Margin |
20.4%
|
9.4%
|
| Return on Equity |
7.7%
|
-24.3%
|
| Dividend Yield |
0.65% |
2.57% |
| FCF Yield |
3.51%
|
3.29%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Starbucks is the world's largest specialty coffee retailer, operating company-owned and licensed coffeehouses across North America, International, and Channel Development segments, with a brand that has historically supported premium pricing and global scale. The business quality is currently strained: revenue declined 1.4% year over year in the most recent quarter, TTM operating margin is 9.4%, …
Accumulation Zones
| Metric |
DHR |
SBUX |
| Zone Low |
$214.89 |
$81.39 |
| Zone High |
$243.54 |
$92.24 |
| In Buy Zone? |
Yes
|
No
|